Long-Term Outcomes of Vaginoplasty With Autologous Buccal Micromucosa

In Brief OBJECTIVE: To evaluate the technical feasibility and anatomical and functional outcomes of one-stage vaginoplasty with autologous buccal micromucosa. METHODS: We retrospectively reviewed our experiences with 38 patients with vaginal agenesis treated with primary surgery from June 2006 to April 2012. All patients underwent transvestibular vaginoplasty with autologous buccal micromucosa. We describe the details of this technique and evaluate the long-term anatomical, functional, and sexual outcomes. RESULTS: A total of 38 patients (33 with Mayer-Rokitansky-Kuster-Hauser syndrome and five with complete androgen insensitivity syndrome) were included in the present study. The mean operative time was 86.4 minutes (range 75–120 minutes). The mean blood loss was 68.5 mL (range 40–80 mL). At a mean follow-up of 33.5 months (range 15–76 months), the mean depth of the neovagina was 8.5±0.66 cm (range 7–10 cm), the mean circumference was 12.3±1.24 cm (range 10–15 cm), and the mean volume was 100±8 mL (range 85–120 mL). By histologic examination, we found the neovaginal mucosa was stratified nonkeratinized squamous mucosa and had secretory function. The mean female sexual function index score of the 32 sexually active patients was 28.8±2.1. No spouse reported discomfort during intercourse. The mean postoperative dependence on the vaginal stent was 15±2.1 months (range 9–20 months). CONCLUSION: Transvestibular vaginoplasty with autologous buccal micromucosa is an effective and feasible approach for patients with Mayer-Rokitansky-Kuster-Hauser syndrome and complete androgen insensitivity syndrome. The procedure has satisfactory long-term anatomical and functional results. LEVEL OF EVIDENCE: III With satisfactory long-term anatomical and functional results, vaginoplasty using autologous buccal micromucosa is an effective and feasible approach for women with vaginal agenesis.